• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy).

作者信息

Pacini F, Pinchera A, Giani C, Grasso L, Baschieri L

出版信息

Clin Endocrinol (Oxf). 1980 Jul;13(1):107-10. doi: 10.1111/j.1365-2265.1980.tb01030.x.

DOI:10.1111/j.1365-2265.1980.tb01030.x
PMID:7438460
Abstract

Measurements of circulating thyroglobulin (hTg) and 131I whole body scan were performed in 101 patients with differentiated thyroid carcinoma who had been subjected to surgical thyroidectomy and 131I ablation of remaining thyroid tissue. All 45 patients with positive scans (i.e. functioning metastases) had elevated hTg concentrations. Of fifty-six patients with negative scans forty-two had undetectable or very low hTg levels and were considered to be free of metastatic thyroid tissue, whereas fourteen showed the presence of non-functioning metastases in the clinical and/or radiological examination. In this group of patients, eleven had elevated serum hTg levels while the other three patients had detectable hTg concentrations within the normal range. These results indicate that serum hTg measurements correlate very well with scan findings and have the added advantage of detecting non-functioning metastases which would not be detected by scanning. We concluded that measurement of serum hTg may be used together with scanning, as the first step in the follow-up of thyroidectomized patients with differentiated thyroid carcinoma.

摘要

相似文献

1
Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy).
Clin Endocrinol (Oxf). 1980 Jul;13(1):107-10. doi: 10.1111/j.1365-2265.1980.tb01030.x.
2
Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.血清甲状腺球蛋白及碘-131全身扫描在转移性分化型甲状腺癌的诊断及治疗评估中的应用
J Nucl Med. 1994 Feb;35(2):257-62.
3
[Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].[转移性分化型甲状腺癌。甲状腺球蛋白放射免疫分析与¹³¹I全身闪烁扫描诊断准确性的比较]
Rofo. 1984 Sep;141(3):306-13. doi: 10.1055/s-2008-1053138.
4
Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.全身扫描与血清甲状腺球蛋白测定在分化型甲状腺癌随访中的互补作用。
Ital J Surg Sci. 1986;16(1):11-5.
5
99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.99m锝-甲氧基异丁基异腈和131碘全身闪烁扫描及初始血清甲状腺球蛋白在分化型甲状腺癌治疗中的应用
J Nucl Med. 2000 Apr;41(4):631-5.
6
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.18F-FDG PET在131I全身扫描阴性的乳头状甲状腺癌中的价值
J Nucl Med. 1999 Jun;40(6):986-92.
7
A comparison of serum thyroglobulin measurements and whole body 131I scanning in the management of treated differentiated thyroid carcinoma.血清甲状腺球蛋白测定与全身¹³¹I扫描在分化型甲状腺癌治疗管理中的比较。
Aust N Z J Med. 1982 Aug;12(4):248-54. doi: 10.1111/j.1445-5994.1982.tb03805.x.
8
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.123I全身扫描及甲状腺球蛋白对分化型甲状腺癌转移灶或复发灶的检测敏感性
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):768-74. doi: 10.1007/s00259-002-0781-x. Epub 2002 Mar 13.
9
Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.氟-18-氟脱氧葡萄糖正电子发射断层扫描在放射性碘扫描阴性且血清甲状腺球蛋白水平升高的分化型甲状腺癌中的应用价值。
Am J Surg. 2000 Jun;179(6):457-61. doi: 10.1016/s0002-9610(00)00381-0.
10
[Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].血清甲状腺球蛋白及¹³¹I全身滞留测量在分化型甲状腺癌转移灶诊断中的临床价值(作者译)
Acta Med Austriaca. 1980;7(4-5):114-9.

引用本文的文献

1
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.重组人促甲状腺素刺激甲状腺球蛋白在分化型甲状腺癌患者随访中的临界值水平
PLoS One. 2015 Jul 31;10(7):e0133852. doi: 10.1371/journal.pone.0133852. eCollection 2015.
2
Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic ¹³¹I whole-body scan and detectable serum thyroglobulin levels.在治疗后¹³¹I全身扫描阴性且血清甲状腺球蛋白水平可检测的患者中,通过不同成像技术(颈部超声、计算机断层扫描和[18F]-FDG正电子发射断层扫描)检测分化型甲状腺癌转移灶。
J Endocrinol Invest. 2014 Oct;37(10):967-72. doi: 10.1007/s40618-014-0134-1. Epub 2014 Jul 29.
3
Thyroid incidentaloma.甲状腺偶发瘤
Indian J Surg Oncol. 2012 Sep;3(3):173-81. doi: 10.1007/s13193-011-0098-y. Epub 2011 Nov 23.
4
Predictive value of serum thyroglobulin in treated patients with differentiated thyroid carcinoma.血清甲状腺球蛋白在分化型甲状腺癌治疗患者中的预测价值。
Indian J Clin Biochem. 1999 Jan;14(1):26-32. doi: 10.1007/BF02869148.
5
I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease.
J Endocrinol Invest. 2004 Nov;27(10):949-53. doi: 10.1007/BF03347538.
6
Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.检测外周血中的甲状腺球蛋白mRNA作为监测甲状腺癌的辅助检查。
Mol Pathol. 2003 Jun;56(3):162-6. doi: 10.1136/mp.56.3.162.
7
Recombinant thyrotropin for detection of recurrent thyroid cancer.重组促甲状腺素用于复发性甲状腺癌的检测。
Trans Am Clin Climatol Assoc. 2002;113:21-30.
8
The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.重组人促甲状腺素(rhTSH)在分化型甲状腺癌管理中的应用。
Rev Endocr Metab Disord. 2000 Apr;1(3):147-54. doi: 10.1023/a:1010018829345.
9
Predictors of thyroid tumor aggressiveness.甲状腺肿瘤侵袭性的预测因素。
West J Med. 1996 Sep;165(3):131-8.
10
Post-surgical follow-up of differentiated thyroid cancer.
J Endocrinol Invest. 1995 Feb;18(2):165-6. doi: 10.1007/BF03349733.